Fluorescence Molecular Tomography: An Imaging Technique for In Vivo Imaging of Fluorescent Protein-tagged Glioblastoma Xenografts in Mouse Model

Published: April 30, 2023

Abstract

Source: Benitez, J. A. et al., Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts. J. Vis. Exp. (2018)

In this video, we describe fluorescence molecular tomography or FMT for in vivo imaging of fluorescent protein-tagged glioblastoma xenografts in mouse models. The technique is useful for elucidating the effects of anti-tumor therapeutics at the molecular level.

Protocol

All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1.FMT Imaging NOTE: According to the experimental aim, the iRFP-tagged glioblastoma cells can be monitored in vivo before, during, or after treatment. For imaging purpose, anesthetize animals using an isoflurane induction chamber, maintain in an imaging cassette during the scanning, and image…

Divulgations

The authors have nothing to disclose.

Materials

Fluorescence Tomography System  PerkinElmer  FMT 2500 XL
TrueQuant Imaging Software Perkin Elmer  7005319
Athymic nude mice Charles River Laboratories  Strain Code 490 (Homozygous)  Prior approval by the Institutional
Animal Care Program and by the
Institutional Biosafety Committee
required.

Tags

check_url/fr/20677?article_type=t

Play Video

Citer Cet Article
Fluorescence Molecular Tomography: An Imaging Technique for In Vivo Imaging of Fluorescent Protein-tagged Glioblastoma Xenografts in Mouse Model. J. Vis. Exp. (Pending Publication), e20677, doi: (2023).

View Video